BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nawaz MH, Sarwar S, Nadeem MA. Post-ERCP Pancreatitis: Risk factors and role of NSAIDs in primary prophylaxis. Pak J Med Sci 2020;36:426-31. [PMID: 32292447 DOI: 10.12669/pjms.36.3.1804] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Du F, Zhang Y, Yang X, Zhang L, Yuan W, Fan H, Ren L. Efficacy of Combined Management with Nonsteroidal Anti-inflammatory Drugs for Prevention of Pancreatitis After Endoscopic Retrograde Cholangiography: a Bayesian Network Meta-analysis. J Gastrointest Surg 2022. [PMID: 35680777 DOI: 10.1007/s11605-022-05352-7] [Reference Citation Analysis]
2 Dubravcsik Z, Hritz I, Keczer B, Novák P, Lovász BD, Madácsy L. Network meta-analysis of prophylactic pancreatic stents and non-steroidal anti-inflammatory drugs in the prevention of moderate-to-severe post-ERCP pancreatitis. Pancreatology 2021;21:704-13. [PMID: 33926821 DOI: 10.1016/j.pan.2021.04.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Zhang Y, Gong Z, Chen S. Clinical application of enhanced recovery after surgery in the treatment of choledocholithiasis by ERCP. Medicine (Baltimore) 2021;100:e24730. [PMID: 33663085 DOI: 10.1097/MD.0000000000024730] [Cited by in F6Publishing: 1] [Reference Citation Analysis]